Ef. Patz et al., SIGNIFICANCE OF PERCUTANEOUS NEEDLE-BIOPSY IN PATIENTS WITH MULTIPLE PULMONARY NODULES AND A SINGLE KNOWN PRIMARY MALIGNANCY, Chest, 107(3), 1995, pp. 601-604
Objective: To determine the necessity of percutaneous lung biopsy in p
atients with a single known primary malignancy and multiple pulmonary
nodules. Design: Retrospective study. Setting: Tertiary care universit
y hospital. Results: We reviewed all percutaneous lung biopsy specimen
s over a 6-year period. One hundred forty-six patients with a single k
nown primary malignancy and multiple pulmonary nodules had biopsies pe
rformed up to 19 years following diagnosis of the primary neoplasm. On
e hundred thirty-seven biopsy specimens (93.8%) were positive for meta
stases. Eight patients (5.5%) had a nondiagnostic biopsy specimen; how
ever, subsequent imaging studies and the clinical course strongly sugg
ested diffuse metastatic disease. One patient (<1%) with breast carcin
oma developed nodules 3 years after initial diagnosis and had resoluti
on without a definitive diagnosis or therapy. Conclusion: Patients wit
h a single known primary malignancy and multiple pulmonary nodules who
present for percutaneous needle biopsy will have pulmonary metastases
in the vast majority of cases. Biopsy in these patients rarely change
s the clinical course as other diagnoses are rarely established.